Pharmaceutical prevention strategy for arteriovenous fistula and arteriovenous graft failure

Pharmaceutical prevention strategy for arteriovenous fistula and arteriovenous graft failure

Abstract Vascular access failure (VAF) is a critical problem in patients undergoing hemodialysis (HD). Importantly, VAF impairs the quality of life in patients undergoing HD while imposing high medical costs. A variety of strategies (e.g., endovascular therapy and surgical reconstruction) for treati...

Full description

Bibliographic Details
Main Authors: Hiroyuki Tsukada, Motonobu Nakamura, Tomohito Mizuno, Nobuhiko Satoh, Masaomi Nangaku
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Renal Replacement Therapy
Subjects:
Arteriovenous fistula
Arteriovenous grafts
Hemodialysis
Vascular access failure
Prevention of vascular access failure
Prophylactic drugs
Online Access:http://link.springer.com/article/10.1186/s41100-019-0210-2

Internet

http://link.springer.com/article/10.1186/s41100-019-0210-2

Similar Items